Evidence map›Paper›PMID 40525856›Full record

ArticlemSystems2025

E Bouda, Y Peng, M M Williams, P K Cassiday, T H Skoff, H Ju, H Fueston, D Kurien, D Morales, M Cole and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSystems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

E BoudaDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Y PengDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
M M WilliamsDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
P K CassidayDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
T H SkoffDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
H JuDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
H FuestonDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
D KurienASRT, Inc., Atlanta, Georgia, USA.
D MoralesASRT, Inc., Atlanta, Georgia, USA.
M ColeDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-9205-9055
E A TravantyColorado State Public Health Laboratory, Denver, Colorado, USA.
D SantoroPublic Health Laboratory, Connecticut Department of Public Health, Rocky Hill, Connecticut, USA.
P M Snippes VagnonePublic Health Laboratory Division, Minnesota Department of Health, Saint Paul, Minnesota, USA.
K MitchellNew York State Public Health Laboratory, New York, New York, USA.
M MartinezOregon State Public Health Laboratory, Hillsboro, Oregon, USA.
Y UnoarumhiDivision of Core Laboratory Services and Response, Office of Laboratory Systems and Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-9088-0360
M BentzDivision of Core Laboratory Services and Response, Office of Laboratory Systems and Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
S NoblesDivision of Core Laboratory Services and Response, Office of Laboratory Systems and Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
J HeuserASRT, Inc., Atlanta, Georgia, USA.
M L TondellaDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
L C PawloskiDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
M R WeigandDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-7278-0160

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decade, genomic characterization of IMPORTANCE: The whooping cough-causing bacterium

Indexed as

Bordetella pertussisGenetic VariationGenome, BacterialWhooping CoughHumansPolymorphism, Single NucleotideWhole Genome SequencingBordetella pertussisgenetic polymorphismsgenome assemblygenome duplicationgenome typinggenomic rearrangementsgenomic variationspulsed-field gel electrophoresisserial passagewhole genome sequencing

Identifiers

PMID40525856
PMCPMC12282162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.